Home › NDC Lookup › RxCUI directory › RxCUI 2471095

Tirbanibulin 0.01 MG/MG Topical Ointment — RxCUI 2471095

RxNorm drug concept · Semantic clinical drug
RxCUI 2471095 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2471095
Official nameTirbanibulin 0.01 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astirbanibulin 1 % Topical Ointment
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tirbanibulin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Actinic keratosis (AK) is a rough, scaly patch on the skin caused by years of sun exposure. Doctors treat it because, left untreated, some AK lesions can develop into a type of ski...
  • What exactly is actinic keratosis, and why does it need treatment?
  • You apply it once a day for 5 days in a row using one small unit-dose packet each time. Spread it evenly over the treatment area on your face or scalp. After applying, wash your ha...
  • How do I actually use Klisyri — do I just rub it in like a regular lotion?
📖 Read our full Tirbanibulin Topical guide →

🕸️ Concept Web — How Tirbanibulin 0.01 MG/MG Topical Ointment Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tirbanibulin 0.01 MG/MG Topical Ointment RxCUI 2471095

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tirbanibulin 2471078
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Klisyri 2471096
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tirbanibulin Topical Ointment 2471094
    • Tirbanibulin Topical Product 2471093
    • Tirbanibulin Topical Ointment [Klisyri] 2471098
    • Klisyri Topical Product 2471099
    • Topical Ointment 316985
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tirbanibulin 0.01 MG/MG SCDC · 2471092
  • Tirbanibulin Topical Ointment SCDF · 2471094
  • Tirbanibulin Topical Product SCDG · 2471093

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2471095 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
16110-0391-05 5 PACKET in 1 CARTON (16110-391-05) / .25 g in 1 PACKET Klisyri Almirall, LLC 2020-12-14
16110-0391-55 5 PACKET in 1 CARTON (16110-391-55) / .35 g in 1 PACKET Klisyri Almirall, LLC 2024-06-07
Observed labelers: Almirall, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.